Loader

Pathways

PathWhiz ID Pathway Meta Data

PW122589

Pw122589 View Pathway
metabolic

tRNA Charging

Pseudomonas aeruginosa
This pathway is a compilation of Escherichia coli tRNA charging reactions involving amino acids transported into the cell. The aminoacyl-tRNA synthetase is an enzyme that attaches the appropriate amino acid onto its tRNA by catalyzing the esterification of a specific cognate amino acid or its precursor to one of all its compatible cognate tRNAs to form an aminoacyl-tRNA, which plays an important role in RNA translation. 20 different Aminoacyl-tRNA synthetases can make 20 different types of aa-tRNA for each amino acid according to the genetic code. This process is called "charging" or "loading" the tRNA with amino acid. Ribosome can transfer the amino acid from tRNA to a growing peptide after the tRNA is charged.

PW122591

Pw122591 View Pathway
metabolic

tRNA Charging 2

Pseudomonas aeruginosa
This pathway is a compilation of Escherichia coli tRNA charging reactions involving biosynthesized amino acids. The aminoacyl-tRNA synthetase is an enzyme that attaches the appropriate amino acid onto its tRNA by catalyzing the esterification of a specific cognate amino acid or its precursor to one of all its compatible cognate tRNAs to form an aminoacyl-tRNA, which plays an important role in RNA translation. 20 different Aminoacyl-tRNA synthetases can make 20 different types of aa-tRNA for each amino acid according to the genetic code. This process is called "charging" or "loading" the tRNA with amino acid. Ribosome can transfer the amino acid from tRNA to a growing peptide after the tRNA is charged.

PW000803

Pw000803 View Pathway
metabolic

tRNA Charging 2

Escherichia coli
This pathway is a compilation of Escherichia coli tRNA charging reactions involving biosynthesized amino acids. The aminoacyl-tRNA synthetase is an enzyme that attaches the appropriate amino acid onto its tRNA by catalyzing the esterification of a specific cognate amino acid or its precursor to one of all its compatible cognate tRNAs to form an aminoacyl-tRNA, which plays an important role in RNA translation. 20 different Aminoacyl-tRNA synthetases can make 20 different types of aa-tRNA for each amino acid according to the genetic code. This process is called "charging" or "loading" the tRNA with amino acid. Ribosome can transfer the amino acid from tRNA to a growing peptide after the tRNA is charged.

PW123859

Pw123859 View Pathway
protein

tRNA Charging: Serine

Homo sapiens
An aminoacyl-tRNA synthetase (aaRS or ARS), also called tRNA-ligase, is an enzyme that attaches the appropriate amino acid onto its tRNA. It does so by catalyzing the esterification of a specific cognate amino acid or its precursor to one of all its compatible cognate tRNAs to form an aminoacyl-tRNA. The 20 different types of aa-tRNA are made by the 20 different aminoacyl-tRNA synthetases, one for each amino acid of the genetic code. This process is sometimes called "charging" or "loading" the tRNA with the amino acid. Once the tRNA is charged, a ribosome can transfer the amino acid from the tRNA onto a growing peptide, according to the genetic code. Aminoacyl-tRNA, therefore, plays an important role in translation, the expression of genes to create proteins. Translation is carried out by ribosomes in the cytoplasm or endoplasmic reticulum after the process of transcription of DNA to RNA in the cell's nucleus (Wikipedia).

PW144328

Pw144328 View Pathway
drug action

Troglitazone Drug Metabolism Action Pathway

Homo sapiens

PW176536

Pw176536 View Pathway
metabolic

Troglitazone Predicted Metabolism Pathway

Homo sapiens
Metabolites of Troglitazone are predicted with biotransformer.

PW147059

Pw147059 View Pathway
metabolic

Trolamine Drug Metabolism Pathway

Homo sapiens

PW146119

Pw146119 View Pathway
drug action

Trolamine polypeptide oleate condensate Drug Metabolism Action Pathway

Homo sapiens

PW127675

Pw127675 View Pathway
drug action

Trolamine salicylate Action Pathway

Homo sapiens
Trolamine salicylate is a nonsteroidal anti-inflammatory agent (NSAID) used for the temporary relief of some minor aches and pains of the muscles and joints associated with backache, lumbago, strains, bruises, sprains, and arthritic or rheumatic pain, pain of tendons and ligaments. This drug is used as a topical analgesic. It targets the prostaglandin G/H synthase-1 (COX-1) and prostaglandin G/H synthase-2 (COX-2) in the cyclooxygenase pathway. The cyclooxygenase pathway begins in the cytosol with phospholipids being converted into arachidonic acid by the action of phospholipase A2. The rest of the pathway occurs on the endoplasmic reticulum membrane, where prostaglandin G/H synthase 1 & 2 convert arachidonic acid into prostaglandin H2. Prostaglandin H2 can either be converted into thromboxane A2 via thromboxane A synthase, prostacyclin/prostaglandin I2 via prostacyclin synthase, or prostaglandin E2 via prostaglandin E synthase. COX-2 is an inducible enzyme, and during inflammation, it is responsible for prostaglandin synthesis. It leads to the formation of prostaglandin E2 which is responsible for contributing to the inflammatory response by activating immune cells and for increasing pain sensation by acting on pain fibers. Trolamine salicylate inhibits the action of COX-1 and COX-2 on the endoplasmic reticulum membrane. This reduces the formation of prostaglandin H2 and therefore, prostaglandin E2 (PGE2). The low concentration of prostaglandin E2 attenuates the effect it has on stimulating immune cells and pain fibers, consequently reducing inflammation and pain.

PW132260

Pw132260 View Pathway
metabolic

Trolamine salicylate Drug Metabolism

Homo sapiens
Trolamine salicylate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Trolamine salicylate passes through the liver and is then excreted from the body mainly through the kidney.